ZielBio

Charlottesville, United States

ZielBio is an early-stage biotechnology company that identifies novel high value disease targets.

$7.5M raised

Sep 2022

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ZielBio raised?

ZielBio has raised $7.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2022.

Who are ZielBio's investors?

ZielBio's investors include Partners Innovation Fund, Morningside, Mass General Brigham Ventures.

Where is ZielBio headquartered?

ZielBio is headquartered in Charlottesville, United States.

What does ZielBio do?

ZielBio is an early-stage biotechnology company that identifies novel high value disease targets.

What stage is ZielBio at?

ZielBio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 27, 2022.

MLA

"ZielBio — Funding & Investors." VCBacked, September 27, 2022, https://www.vcbacked.co/company/zielbio. Accessed July 2, 2026.

APA

VCBacked. (2022). ZielBio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/zielbio

Wikipedia (cite web)

{{cite web |title=ZielBio — Funding & Investors |url=https://www.vcbacked.co/company/zielbio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 27, 2022.